Last $0.12 USD
Change Today 0.00 / 0.00%
Volume 46.7K
DRIO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

labstyle innovations corp (DRIO) Snapshot

Open
$0.12
Previous Close
$0.12
Day High
$0.12
Day Low
$0.12
52 Week High
01/10/14 - $13.10
52 Week Low
11/14/14 - $0.10
Market Cap
2.0M
Average Volume 10 Days
165.8K
EPS TTM
$4.87
Shares Outstanding
16.2M
EX-Date
--
P/E TM
0.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for LABSTYLE INNOVATIONS CORP (DRIO)

labstyle innovations corp (DRIO) Related Bloomberg News

View More Bloomberg News

labstyle innovations corp (DRIO) Related Businessweek News

No Related Businessweek News Found

labstyle innovations corp (DRIO) Details

LabStyle Innovations Corp., a mobile health company, develops and commercializes a patent-pending technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its primary product is Dario, which is a mobile, cloud-based, diabetes management solution, which includes novel software applications combined with a pocket-sized, blood glucose monitoring device. The company’s product consists of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge, and a smartphone-driven glucose reader adaptor, coupled with a smartphone app and cloud-based data services. LabStyle Innovations Corp. is pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid blood, urine, and saliva tests using mobile devices and cloud-based services. The company was founded in 2011 and is headquartered in Ramat Gan, Israel.

18 Employees
Last Reported Date: 10/31/14
Founded in 2011

labstyle innovations corp (DRIO) Top Compensated Officers

Acting Chairman of The Board, Chief Executive...
Total Annual Compensation: $127.4K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $11.0K
Compensation as of Fiscal Year 2013.

labstyle innovations corp (DRIO) Key Developments

LabStyle Innovations Corp. Appoints Peter Kash and Hila Karah to the Board of Directors

LabStyle Innovations Corp. announced that Dr. Peter Kash and Ms. Hila Karah have been appointed to serve on the company's Board of Directors. Dr. Kash and Ms. Karah bring significant experience in commercialization, finance and corporate governance of life science companies to LabStyle's board. Ms. Karah is expected to serve on the Compensation and Nominating Committees of the board. Dr. Kash and Ms. Karah are the designated appointees of Dicilyon Consulting and Investment Ltd. Dr. Kash currently serves as Executive Chairman of iOS app developer Time Flash LLC. Ms. Karah is an independent business consultant and an investor in several high-tech, biotech and Internet companies.

LabStyle Innovations Corp. Announces Unaudited Consolidated Earnings Results for Third Quarter and Nine Months Ended September 30, 2014

LabStyle Innovations Corp. announced unaudited consolidated earnings results for third quarter and nine months ended September 30, 2014. For the quarter, the company reported net loss as reported of $6,333,000 against $3,471,000 a year ago. LBITDA was $2,404,000 against $2,974,000 a year ago. NON-GAAP adjusted LBITDA was $2,081,000 or $0.21 per share against $2,231,000 or $0.55 per share a year ago. Operating loss was $2,507,000 against $3,238,000 a year ago. Net loss was $3,077,000 or $0.66 basic and diluted per share, compared to $3,471,000 or $0.85 per share basic and diluted a year ago. The non-GAAP adjusted loss, for the third quarter of 2014 was approximately $2,081,000, or $0.21 per share, compared with a non-GAAP adjusted loss for the third quarter of 2013 of approximately $2,231,000, or $0.55 per share. For the nine months, the company reported net loss as reported of $12,571,000 against $13,985,000 a year ago. LBITDA was $8,317,000 against $9,332,000 a year ago. NON-GAAP adjusted LBITDA was $6,795,000 or $1.10 per share against $5,728,000 or $1.61 per share a year ago. Operating loss was $8,778,000 against $9,910,000 a year ago. Net loss was $9,315,000 or $2.23 diluted per share, compared to $13,985,000 or $3.95 per share diluted a year ago. The non-GAAP adjusted loss for the first nine months of 2014 was approximately $6,795,000, or $0.10 per share, versus a non-GAAP adjusted loss of approximately $5,728,000, or $1.61 per share, in the corresponding period in 2013. The company used approximately $6,168,000 in cash to fund operating activities during the first nine months of 2014.

Shetron Ltd. Announces Consolidated Unaudited Earnings Results for Second Quarter and Six Months Ended June 30, 2014

LabStyle Innovations Corp. announced consolidated unaudited earnings results for second quarter and six months ended June 30, 2014. For the quarter, the company reported LBITDA of $3,443,000, NON-GAAP adjusted LBITDA of $2,753,000, operating loss of $3,603,000, net loss of $3,254,000 or $0.15 diluted per share, compared to the LBITDA of $3,400,000, NON-GAAP adjusted LBITDA of $2,251,000, operating loss of $3,596,000, net loss of $5,286,000 or $0.29 diluted per share, for the same quarter a year ago. For the year to date, the company reported LBITDA of $5,913,000, NON-GAAP adjusted LBITDA of $4,714,000, operating loss of $6,271,000, net loss of $6,238,000 or $0.29 diluted per share, compared to the LBITDA of $6,358,000, NON-GAAP adjusted LBITDA of $3,497,000, operating loss of $6,672,000, net loss of $10,513,000 or $0.63 diluted per share, for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRIO:US $0.12 USD 0.00

DRIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DRIO.
View Industry Companies
 

Industry Analysis

DRIO

Industry Average

Valuation DRIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABSTYLE INNOVATIONS CORP, please visit www.mydario.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.